The present study investigated the prognostic biomarkers FGFR2, VEGF, TRAIL-R1, and TRAIL-R2 alongside clinicopathological data to improve outcome prediction in patients with resected HCC. Here, VEGFA is linked to hepatocellular carcinoma.